Choroidal neovascularisation and Maculopathy - from FDA reports
Maculopathy is found among people with Choroidal neovascularisation, especially for people who are male, 60+ old, take medication Lucentis and have Age-related macular degeneration. This review analyzes which people have Maculopathy with Choroidal neovascularisation. It is created by eHealthMe based on reports of 17 people who have Choroidal neovascularisation from FDA , and is updated regularly.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Aug, 19, 2017
17 people who have Choroidal Neovascularisation and Maculopathy are studied.
Number of reports submitted per year:
Gender of people who have Choroidal Neovascularisation and experience Maculopathy *:
- female: 41.67 %
- male: 58.33 %
Age of people who have Choroidal Neovascularisation and experience Maculopathy *:
- 0-1: 0.0 %
- 2-9: 9.09 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 18.18 %
- 60+: 72.73 %
Top co-existing conditions for these people *:
- Macular Degeneration (1 person, 5.88%)
- Detachment Of Retinal Pigment Epithelium (1 person, 5.88%)
- Age-Related Macular Degeneration (1 person, 5.88%)
Most common drugs for these people *:
- Visudyne (5 people, 29.41%)
- Lucentis (5 people, 29.41%)
- Zetia (2 people, 11.76%)
- Pitavastatin Calcium (2 people, 11.76%)
- Levofloxacin (2 people, 11.76%)
Top symptoms for these people *:
- Visual Acuity Reduced (6 people, 35.29%)
- Retinal Disorder (3 people, 17.65%)
- Herpes Zoster (3 people, 17.65%)
- Macular Hole (2 people, 11.76%)
- Cataract (2 people, 11.76%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Do you have Maculopathy and Choroidal neovascularisation?
Expand the study to include reports from both FDA and eHealthMeMaculopathy and Choroidal neovascularisation from FDA and eHealthMe reports
Choroidal neovascularisation (creation of new blood vessels in vascular layer of eye) (latest reports from 1,798 Choroidal neovascularisation patients)
Maculopathy (condition or disease of the macula, the small spot in the retina where vision is keenest) has been reported by people with high blood pressure, rheumatoid arthritis, multiple sclerosis, maculopathy, osteoporosis (latest reports from 2,094 Maculopathy patients).